Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC10A5 pseudogene 1 (SLC10A5P1) is a non-coding pseudogene related to the solute carrier family 10 member 5 gene (SLC10A5), which is part of the sodium/bile acid cotransporter family. As a pseudogene, SLC10A5P1 does not encode a functional protein, and there is no evidence it acts as a therapeutic target, nor is it implicated as a biomarker or drug target in any biological or disease context[3]. The functional gene SLC10A5 encodes a transporter potentially involved in bile acid and bile salt transport, but the pseudogene variant, SLC10A5P1, is not functional and has no known biological or clinical significance[3][4]. Summary of findings: - SLC10A5P1 is a pseudogene, meaning it resembles a gene but is nonfunctional and does not produce a protein. - No evidence in available scientific or genetic databases (such as GeneCards) that SLC10A5P1 is a protein-coding target, transporter, or involved in any therapeutic, diagnostic, or pathophysiological role[3]. - The functional SLC10A5 gene itself (not the pseudogene) has been studied for bile acid transport, but this is unrelated to SLC10A5P1[1][4]. In conclusion, SLC10A5P1 is not a target of therapeutic interest, is not a transporter, receptor, enzyme, or other drug target, and is not associated with any known diseases or drug interactions. Its mention as a target likely represents a confusion with the protein-coding SLC10A5 gene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC10A5 pseudogene 1 (SLC10A5P1).